Unigestion Holding’s Hologic HOLX Stock Holding History

Unigestion Holding’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-6,353	Closed	-$362K	–	201
2020 Q2	$362K	Buy	+6,353	New	+$312K	0.01%	183

Other funds holding HOLX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Unigestion Holding's HOLX Position: Q3 2020 in Review

Unigestion Holding sold out of Hologic (HOLX) in Q3 2020, closing a stake of 6,353 shares — an estimated $362K sold.

Unigestion Holding first reported a position in HOLX in Q2 2020 and held it in 1 quarter. The position peaked at $362K in Q2 2020. 567 funds tracked by Wall St. Rank hold HOLX as of Q3 2020.

Unigestion Holding reported no remaining Hologic position as of Q3 2020 after selling out during the quarter.
Unigestion Holding sold 6,353 Hologic shares in Q3 2020, an estimated $362K.
Unigestion Holding first reported a position in Hologic in Q2 2020 and held it in 1 quarter.
Unigestion Holding's Hologic position peaked at $362K in Q2 2020.
567 funds tracked by Wall St. Rank held Hologic as of Q3 2020.

Based on Unigestion Holding's 13F filing for Q3 2020, filed 10 Nov 2020.